Surgical Science Sweden AB (publ) (STO:SUS)

Sweden flag Sweden · Delayed Price · Currency is SEK
141.40
+1.20 (0.86%)
May 7, 2025, 1:54 PM CET
-8.24%
Market Cap 7.15B
Revenue (ttm) 884.09M
Net Income (ttm) 131.65M
Shares Out 51.03M
EPS (ttm) 2.58
PE Ratio 54.34
Forward PE 32.39
Dividend n/a
Ex-Dividend Date n/a
Volume 19,633
Average Volume 94,630
Open 140.50
Previous Close 140.20
Day's Range 138.10 - 142.90
52-Week Range 106.40 - 192.40
Beta 0.62
RSI 60.24
Earnings Date May 14, 2025

About STO:SUS

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra... [Read more]

Sector Healthcare
Founded 1997
Employees 274
Stock Exchange Nasdaq Stockholm
Ticker Symbol SUS
Full Company Profile

Financial Performance

In 2024, STO:SUS's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial Statements

News

There is no news available yet.